001     127177
005     20240228140909.0
024 7 _ |a 10.1158/0008-5472.CAN-15-0997
|2 doi
024 7 _ |a pmid:26069251
|2 pmid
024 7 _ |a 0008-5472
|2 ISSN
024 7 _ |a 0099-7013
|2 ISSN
024 7 _ |a 0099-7374
|2 ISSN
024 7 _ |a 1538-7445
|2 ISSN
024 7 _ |a altmetric:4138589
|2 altmetric
037 _ _ |a DKFZ-2017-03203
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Mudduluru, Giridhar
|0 P:(DE-He78)60800c1f5fff167ebb246fc76416cee6
|b 0
|e First author
|u dkfz
245 _ _ |a A Systematic Approach to Defining the microRNA Landscape in Metastasis.
260 _ _ |a Philadelphia, Pa.
|c 2015
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1524123771_11666
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The microRNA (miRNA) landscape changes during the progression of cancer. We defined a metastasis-associated miRNA landscape using a systematic approach. We profiled and validated miRNA and mRNA expression in a unique series of human colorectal metastasis tissues together with their matched primary tumors and corresponding normal tissues. We identified an exclusive miRNA signature that is differentially expressed in metastases. Three of these miRNAs were identified as key drivers of an EMT-regulating network acting though a number of novel targets. These targets include SIAH1, SETD2, ZEB2, and especially FOXN3, which we demonstrated for the first time as a direct transcriptional suppressor of N-cadherin. The modulation of N-cadherin expression had significant impact on migration, invasion, and metastasis in two different in vivo models. The significant deregulation of the miRNAs defining the network was confirmed in an independent patient set as well as in a database of diverse malignancies derived from more than 6,000 patients. Our data define a novel metastasis-orchestrating network based on systematic hypothesis generation from metastasis tissues.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Antigens, CD
|2 NLM Chemicals
650 _ 7 |a CDH2 protein, human
|2 NLM Chemicals
650 _ 7 |a Cadherins
|2 NLM Chemicals
650 _ 7 |a Cell Cycle Proteins
|2 NLM Chemicals
650 _ 7 |a FOXN3 protein, human
|2 NLM Chemicals
650 _ 7 |a Homeodomain Proteins
|2 NLM Chemicals
650 _ 7 |a MIRN135 microRNA, human
|2 NLM Chemicals
650 _ 7 |a MIRN210 microRNA, human
|2 NLM Chemicals
650 _ 7 |a MIRN218 microRNA, human
|2 NLM Chemicals
650 _ 7 |a MicroRNAs
|2 NLM Chemicals
650 _ 7 |a Nuclear Proteins
|2 NLM Chemicals
650 _ 7 |a Repressor Proteins
|2 NLM Chemicals
650 _ 7 |a ZEB2 protein, human
|2 NLM Chemicals
650 _ 7 |a Histone-Lysine N-Methyltransferase
|0 EC 2.1.1.43
|2 NLM Chemicals
650 _ 7 |a Set2 protein, human
|0 EC 2.1.1.43
|2 NLM Chemicals
650 _ 7 |a Ubiquitin-Protein Ligases
|0 EC 2.3.2.27
|2 NLM Chemicals
650 _ 7 |a seven in absentia proteins
|0 EC 2.3.2.27
|2 NLM Chemicals
700 1 _ |a Abba, Mohammed Lawan
|0 P:(DE-He78)54a8723466e5d487247f3d93d51c66bc
|b 1
|u dkfz
700 1 _ |a Batliner, Jasmin
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Patil, Nitin Shaligram
|0 P:(DE-He78)e22573706cfe9748cc0e45a526c2bfef
|b 3
|u dkfz
700 1 _ |a Scharp, Maike
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Lunavat, Taral R
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Leupold, Jörg Hendrik
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Oleksiuk, Olga
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Juraeva, Dilafruz
|0 P:(DE-He78)5482b9f7e4c4ff6a3a4d7c860a1bce61
|b 8
|u dkfz
700 1 _ |a Thiele, Wilko
|b 9
700 1 _ |a Rothley, Melanie
|b 10
700 1 _ |a Benner, Axel
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 11
|u dkfz
700 1 _ |a Ben-Neriah, Yinon
|b 12
700 1 _ |a Sleeman, Jonathan
|b 13
700 1 _ |a Allgayer, Heike
|0 P:(DE-He78)69067807288b48415ceb4abc43b9ad54
|b 14
|e Last author
|u dkfz
773 _ _ |a 10.1158/0008-5472.CAN-15-0997
|g Vol. 75, no. 15, p. 3010 - 3019
|0 PERI:(DE-600)2036785-5
|n 15
|p 3010 - 3019
|t Cancer research
|v 75
|y 2015
|x 1538-7445
909 C O |o oai:inrepo02.dkfz.de:127177
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)60800c1f5fff167ebb246fc76416cee6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)54a8723466e5d487247f3d93d51c66bc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)e22573706cfe9748cc0e45a526c2bfef
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)5482b9f7e4c4ff6a3a4d7c860a1bce61
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)69067807288b48415ceb4abc43b9ad54
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER RES : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER RES : 2015
920 1 _ |0 I:(DE-He78)L201-20160331
|k L201
|l DKTK Berlin
|x 0
920 1 _ |0 I:(DE-He78)G360-20160331
|k G360
|l KKE Molekulare Onkologie solider Tumoren
|x 1
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 2
920 1 _ |0 I:(DE-He78)G200-20160331
|k G200
|l Angewandte Bioinformatik
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)L201-20160331
980 _ _ |a I:(DE-He78)G360-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)G200-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21